A vaccine that works in New York is on the verge of being tested in New Jersey, the first time a U.S. city has done so.
The New York state Department of Health and Mental Hygiene has announced the vaccine has been approved for use in the state.
The vaccine is called NVV-4 and was developed by NVNX, which specializes in the use of advanced technologies to develop vaccines.
The agency says the vaccine is safe and effective, but only in people who have not been exposed to the pandemic.
It has also recommended the vaccine be given to people at higher risk of developing the pandemics new coronavirus.
In September, the agency said it had approved a new, improved version of the vaccine in New Mexico, where the pandemaker was most active in the last two months of the year.
The New Jersey-based NVNx has also developed the same vaccine for use elsewhere in the United States.
New Jersey, New York, and other states are expected to test the vaccine by March 10.
The new vaccine is expected to be administered at a public health facility that is not a hospital or a health care facility, and it has not been tested for human or animal transmission, the New York Department of health and mental health said.
The department has asked people who live in New England to wear masks while in a public place.
It is not known if the vaccine will be administered in other states.
The state has been experiencing high levels of coronaviruses, which can cause serious illnesses and even death, since the beginning of the pandemanas outbreak, and the number of cases has increased in recent days.